Pneumonia Clinical Trial
Official title:
Prophylactic Bronchoscopy After Inhalation Injury in Burn Patients
The investigators hypothesize that the scheduled use of bronchoscopy on a regular basis after inhalation injury in burn patients will improve outcome by providing pulmonary hygiene, decrease the incidence of pneumonia, and detect pneumonia earlier than standard treatment without bronchoscopy.
The role of bronchoscopy in most hospitals has been limited to obtaining lavage fluid for
culture and assessing the degree of airway injury, which has been shown to be predictive of
outcome. Severe inhalation injury, which is characterized by pulmonary edema, bronchial
edema, and secretions, can occlude the airway and lead to atelectasis and pneumonia.
Aggressive use of bronchoscopy is highly effective in removing foreign particles and
accumulated secretions that worsen the inflammatory response and impede ventilation. While
it seems intuitive that bronchoscopy would improve pulmonary hygiene by removing secretions
and denuded epithelial slough in burn patients, there has not been any published data to
support or deter the use of bronchoscopy for inhalation injury nor document an improvement
in morbidity or mortality secondary to bronchoscopy as a therapeutic intervention.
Recent research has shown that the process of intubation for mechanical ventilation provides
a portal for bacterial contamination, after which the damaged tracheobronchial mucosa
quickly becomes colonized with pathogenic organisms in over 50% of the patients.
Furthermore, within 15 minutes of smoke inhalation, there is significant airway edema and
thickening, more prominently in the lower trachea than the upper portion. These factors
place the patient with inhalation injury at high risk for pneumonia.
We have used the National Burn Repository data to previously show that patients who receive
aggressive use of bronchoscopy after inhalation injury have an improved outcome in terms of
decreased ventilator days, decreased ICU length of stay, decreased incidence of pneumonia,
and a trend towards improved mortality. However, that data was unable to document why. It
was also unable to confirm that the findings were not due to institutional bias. Therefore,
one of the conclusions from that study was that a prospective trial is needed to confirm the
findings.
Our hypothesis is that a scheduled and sequential use of bronchoscopy after inhalation
injury as a therapeutic tool to remove secretions, slough, carbonaceous material, and screen
for the early detection of pneumonia by bronchoalveolar lavage (BAL) will improve outcome.
We will attempt to document this improvement by using the following endpoints: length of ICU
stay, length of hospital stay, ventilator days, incidence of pneumonia, overall morbidity
and mortality with and without bronchoscopy.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04244474 -
Effect of Vitamin D Supplementation on Improvement of Pneumonic Children
|
Phase 1/Phase 2 | |
| Completed |
NCT05815264 -
Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Chinese Population Aged 2 Years and Above
|
Phase 1 | |
| Recruiting |
NCT04589936 -
Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care
|
N/A | |
| Completed |
NCT02905383 -
The Effect of Exercise on Physical Function and Health in Older People After Discharge From Hospital
|
N/A | |
| Completed |
NCT06210737 -
A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months，7 Months-5 Years
|
Phase 4 | |
| Terminated |
NCT03944551 -
Bubble Continuous Positive Airway Pressure for Children With Severe Pneumonia in Mali, Africa
|
N/A | |
| Terminated |
NCT04660084 -
Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAP
|
N/A | |
| Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
| Withdrawn |
NCT05702788 -
Efficacy and Safety of Jaktinib in Participants With Severe Novel Coronavirus Pneumonia(COVID-19)
|
Phase 2 | |
| Not yet recruiting |
NCT04171674 -
Pharmacokinetics of High-dose Ceftobiprole in Community-acquired Pneumonia Under Mechanical Ventilation.
|
N/A | |
| Active, not recruiting |
NCT03140163 -
Screening for Pneumonia: A Comparison of Ultra Low Dose Chest CT [ULD-CT] and Conventional Chest Radiography [CXR]
|
N/A | |
| Completed |
NCT02638649 -
Prehospital Use of Ultrasound in Undifferentiated Shortness of Breath
|
||
| Completed |
NCT02864420 -
Hospitalization at Home: The Acute Care Home Hospital Program for Adults
|
N/A | |
| Recruiting |
NCT02515565 -
Physiotherapy in Patients Hospitalized Due to Pneumonia.
|
N/A | |
| Completed |
NCT02105298 -
Effect of Volume and Type of Fluid on Postoperative Incidence of Respiratory Complications and Outcome (CRC-Study)
|
N/A | |
| Completed |
NCT01416519 -
Physiotherapy Technique Decreases Respiratory Complications After Cardiac Operation
|
N/A | |
| Completed |
NCT01399723 -
Amoxicillin Versus Benzyl Penicillin for Treatment of Children Hospitalised With Severe Pneumonia
|
Phase 3 | |
| Completed |
NCT01446926 -
Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants
|
Phase 1 | |
| Completed |
NCT01416506 -
Community-Acquired Pneumonia (CAP) Surveillance
|
N/A | |
| Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A |